ELYM - eliemtx.com Qarzning balans kapitallashuviga nisbati
Eliem Therapeutics o'z patentlarining global salohiyatidan foydalangan holda asab tizimi buzilishlari uchun kengaytiriladigan davolash usullarini ishlab chiqadi. GURU.Markets tomonidan taqdim etilgan qarzning kapitalga nisbati tendentsiyasi shuni ko'rsatadiki, 0.00 ushbu ko'rsatkich uchun yangi qiymatga aylanmoqda. Daromad antidepressantlar va epileptik qarshi dori vositalarining bozorga chiqarilishiga asoslangan, zamonaviy R&D bazasi va ishonchli hamkorlar esa farmatsevtika mahsulotlarining uzluksiz chiqarilishini ta'minlaydi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ELYM_-_Eliem-Therapeutics_-_Debt-to-Net-Assets-Ratio "Eliem Therapeutics - ELYM Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 03.10.2024) | 👁️GURU.Markets👁️")
eliemtx.com (ELYM) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Eliem Therapeutics|ELYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Eliem Therapeutics Inc.|ELYM - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar Eliem Therapeutics Inc.|ELYM - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Eliem Therapeutics
Kompaniyaning fundamental tahlili:Eliem - ELYM
Ushbu ko'rsatkich jami kapital qiymatiga nisbatan qarz mablag'larining ulushini o'lchaydi va majburiyatlar xizmatining haqiqiy xarajatlarini aks ettiradi. Eliem Therapeutics (ELYM) uchun ushbu hisob-kitob yangi aktivlar sotib olingandan so'ng neyroimmunologiya loyihalari portfelini kengaytirishda hal qiluvchi ahamiyatga ega. Qarzning korxona qiymatiga nisbatini tahlil qilish orqali investor bozor shovqinini haqiqiy kredit yukidan ajratadi. Optimal muvozanat investitsiya tanqisligining oldini oladi va kompaniyaning uzoq muddatli moliyaviy barqarorligini tasdiqlaydi.
Eliem Therapeutics kimlar bilan raqobatlashadi
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar VKTX (Viking Therapeutics)|Balans qiymatiga qarzlar SUPN|Qarzning balans kapitallashuviga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|Qarzning balans kapitallashuviga nisbati Denali (DNLI)|Balans kapitallashuviga qarzlar HRMY|Sof aktivlarga qarzlar Biohaven Corp BHVN|AMLX (Amylyx Pharmaceuticals) - Balans kapitallashuviga qarzlar|TRVI: Balans qiymatiga qarzlar|PRAX (Praxis Precision Medicines, Inc.) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Anavex|CBLL - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati prothena.com (PRTA)|Qarzning balans qiymatiga nisbati Alector, Inc.|Qarzning balans kapitaliga nisbati annexonbio.com (ANNX)|Balans kapitallashuviga qarzlar Omeros|Qarzning sof aktivlarga nisbati Neurogene Inc NGNE|ACIU (AC Immune Corp) - Balans kapitallashuviga qarzlar|VYGR: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Neumora Therapeutics NMRA|scilexholding.com (SCLX) - Qarzning sof aktivlarga nisbati|TVGN (Tevogen Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ACOG|CGTX - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Inhibikase Pharma (IKT)|SAVA: Balans kapitallashuviga qarzlar|ASRT - Balans qiymatiga qarzlar|Coya - Qarzning balans qiymatiga nisbati|Vistagen Therapeutics (VTGN) - Balans kapitallashuviga qarzlar|OVID - Qarzning balans qiymatiga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans kapitaliga nisbati|CRVO: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Alterity Therapeutics Ltd|Balans kapitallashuviga qarzlar CLNN (Clene Inc.)|Qarzning balans qiymatiga nisbati PEPG (pepgen.com)|Qarzning balans kapitallashuviga nisbati JUNS|Sof aktivlarga qarzlar Relmada Corp RLMD|ANVS (Annovis Bio, Inc.) - Balans kapitallashuviga qarzlar|GRCE: Balans qiymatiga qarzlar|Firefly Neuroscience (AIFF) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Klotho Neurosciences|Qarzning balans qiymatiga nisbati NRSN (NeuroSense Therapeutics Ltd)|Balans qiymatiga qarzlar RVPH|Qarzning balans kapitallashuviga nisbati MTVA (MetaVia Inc)|Qarzning balans qiymatiga nisbati NRXS (neuraxis.com)|HSDT - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Passage Bio Inc. PASG|NEUP (Neuphoria) - Balans kapitallashuviga qarzlar|Minerva (NERV) - Balans qiymatiga qarzlar|ATHA: Qarzning balans qiymatiga nisbati|ADXN (addextherapeutics.com) - Balans kapitallashuviga qarzlar|ALZN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati CYCN|Protagenic Therapeutics - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar pasitheaclinics.com (KTTA)|CRGT: Balans kapitallashuviga qarzlar|avenuetx.com - Balans qiymatiga qarzlar|BCLI - Qarzning balans kapitallashuviga nisbati|CARA - Qarzning balans kapitallashuviga nisbati|Chromocell Therapeutics Corporation - Balans kapitallashuviga qarzlar|Intra-Cellular Therapies, Inc. (ITCI) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar LBPH (Longboard Pharmaceuticals)|Balans qiymatiga qarzlar MRNS|Qarzning balans kapitallashuviga nisbati NKGN (NKGen Biotech)|Qarzning balans qiymatiga nisbati NeuroBo Pharmaceuticals Inc NRBO|Qarzning balans qiymatiga nisbati Sage Therapeutics, Inc|SNPX - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati Trevena, Inc. TRVN|VIGL - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Anew Medical WENA|Cerevel Therapeutics Inc (CERE) - Qarzning sof aktivlarga nisbati